Sam Khan

454 total citations
18 papers, 96 citations indexed

About

Sam Khan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sam Khan has authored 18 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sam Khan's work include Lung Cancer Treatments and Mutations (4 papers), Global Cancer Incidence and Screening (3 papers) and Cancer therapeutics and mechanisms (3 papers). Sam Khan is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Global Cancer Incidence and Screening (3 papers) and Cancer therapeutics and mechanisms (3 papers). Sam Khan collaborates with scholars based in United Kingdom, Canada and Norway. Sam Khan's co-authors include Giuseppe Garcea, Ashley R. Dennison, Andrew M. Fry, Richard Bayliss, Laura O’Regan, Michael Sweeting, Gareth J. Miles, Yuk Ting, Suzanne Darby and Karen Brown and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Clinical Epidemiology.

In The Last Decade

Sam Khan

14 papers receiving 94 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sam Khan United Kingdom 6 31 26 25 23 20 18 96
Anne‐Laure Védié France 6 41 1.3× 15 0.6× 44 1.8× 34 1.5× 44 2.2× 11 153
Jigjidsuren Chinburen Mongolia 5 17 0.5× 27 1.0× 27 1.1× 51 2.2× 44 2.2× 9 108
Yunpeng Gao United States 6 17 0.5× 13 0.5× 45 1.8× 21 0.9× 17 0.8× 9 93
Valentina Zanuso Italy 6 51 1.6× 19 0.7× 20 0.8× 33 1.4× 14 0.7× 16 93
Yehia I. Abugabal United States 3 24 0.8× 13 0.5× 15 0.6× 46 2.0× 26 1.3× 12 80
Yuye Zhang China 5 41 1.3× 21 0.8× 35 1.4× 5 0.2× 12 0.6× 9 100
Edward Y. Zhu United States 5 28 0.9× 26 1.0× 16 0.6× 9 0.4× 21 1.1× 13 73
Olivier Ingster France 6 55 1.8× 8 0.3× 42 1.7× 12 0.5× 23 1.1× 6 105
Letizia Amadori United States 5 21 0.7× 8 0.3× 33 1.3× 16 0.7× 18 0.9× 13 109
Xuetao Shi China 6 22 0.7× 10 0.4× 14 0.6× 38 1.7× 17 0.8× 18 86

Countries citing papers authored by Sam Khan

Since Specialization
Citations

This map shows the geographic impact of Sam Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Khan more than expected).

Fields of papers citing papers by Sam Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Khan. The network helps show where Sam Khan may publish in the future.

Co-authorship network of co-authors of Sam Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Khan. A scholar is included among the top collaborators of Sam Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Khan. Sam Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Cai, Yutong, et al.. (2025). Relationship between household air pollution and lung cancer in never smokers in high-income countries: a systematic review. BMJ Open. 15(6). e093870–e093870. 2 indexed citations
3.
Munárriz, B., et al.. (2025). Update advances in anaplastic lymphoma kinase‐positive non–small cell lung cancer treatment. Cancer. 131(S1). e35786–e35786. 2 indexed citations
4.
Khan, Sam, Thomas K. Waddell, Kazuhiro Yasufuku, et al.. (2024). ctDNA-Lung-DETECT: ctDNA outcomes for resected early stage non-small cell lung cancers at 12 months.. Journal of Clinical Oncology. 42(16_suppl). 8018–8018. 2 indexed citations
5.
Lambert, Paul C., et al.. (2024). The long-lasting impacts of the COVID-19 pandemic on population-based cancer survival: what are the implications for data analysis?. British Journal of Cancer. 132(8). 673–678. 1 indexed citations
6.
7.
Fittall, Matthew W., Justin Liu, James J. Clark, et al.. (2023). The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research. British Journal of Cancer. 128(11). 1977–1980. 2 indexed citations
8.
Khan, Sam, Robert C. Rintoul, Coral Pepper, et al.. (2023). Lung cancer in never smokers (LCINS): development of a UK national research strategy. PubMed. 1(1). 21–21. 6 indexed citations
9.
O’Dowd, Emma, Samuel WD Merriel, Vinton W.T. Cheng, et al.. (2023). Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review. BMC Cancer. 23(1). 820–820. 5 indexed citations
10.
11.
O’Regan, Laura, Jene Choi, Josephina Sampson, et al.. (2022). EML4-ALK Variant 3 Promotes Mitotic Errors and Spindle Assembly Checkpoint Deficiency Leading to Increased Microtubule Poison Sensitivity. Molecular Cancer Research. 20(6). 854–866. 11 indexed citations
12.
Soares, Marta, et al.. (2022). Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups. Frontiers in Oncology. 12. 943154–943154. 2 indexed citations
13.
O’Regan, Laura, et al.. (2022). Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer. Cancers. 14(14). 3452–3452. 9 indexed citations
14.
15.
Khan, Sam, Gareth J. Miles, Kevin West, et al.. (2022). Ex vivo explant model of adenoma and colorectal cancer to explore mechanisms of action and patient response to cancer prevention therapies. Mutagenesis. 37(5-6). 227–237. 7 indexed citations
16.
Zakeri, Nekisa, Yuk Ting, Joanne O’Rourke, et al.. (2021). Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit. British Journal of Cancer. 125(10). 1350–1355. 28 indexed citations
17.
Thompson, Beti & Sam Khan. (2016). Aging Men and Prostate Cancer. Journal für Kardiologie (Krause & Pachernegg GmbH). 12(4). 396–398. 1 indexed citations
18.
Khan, Sam, Ashley R. Dennison, & Giuseppe Garcea. (2015). Medical therapy for polycystic liver disease. Annals of The Royal College of Surgeons of England. 98(1). 18–23. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Laure Védié Breakdown of academic impact, for papers by Jigjidsuren Chinburen Breakdown of academic impact, for papers by Yunpeng Gao Breakdown of academic impact, for papers by Valentina Zanuso Breakdown of academic impact, for papers by Yehia I. Abugabal Breakdown of academic impact, for papers by Yuye Zhang Breakdown of academic impact, for papers by Edward Y. Zhu Breakdown of academic impact, for papers by Olivier Ingster Breakdown of academic impact, for papers by Letizia Amadori Breakdown of academic impact, for papers by Xuetao Shi
Rankless by CCL
2026